Cytokine single nucleotide polymorphism role in acute renal failure

Contributions to Nephrology

Volumn 144, Issue , 2004, Pages 63-75

  Liangos, Orfeas ^a   Balakrishnan, Vaidyanathapuram S ^a   Pereira, Brian J G ^a   Jaber, Bertrand L ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOKINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL; CHROMOSOME MAP; DOWN REGULATION; GENETIC POLYMORPHISM; GENETICS; GENOME; HUMAN; METABOLISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION;

ANIMALS; CHROMOSOME MAPPING; CISPLATIN; CYTOKINES; DOWN-REGULATION; GENOME, HUMAN; HUMANS; INTERLEUKIN-10; KIDNEY FAILURE, ACUTE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 3342929730     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (67)

1. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 1983;74:243-248.
2. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-348.
3. Conference ACoCPSoCCMC: Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;13:818-822.
4. Opal S, DePalo V: Anti-inflammatory cytokines. Chest 2000;117:1162-1172.
5. De Waal Malefyt F, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
6. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
7. Perianayagam M, Jaber B, Guo D, King A, Pereira B, Balakrishnan V: Defective interleukin-10 synthesis by peripheral blood mononuclear cells among hemodialysis patients. Blood Purif 2002; 20:543-550.
8. Fouqueray B, Philippe C, Herbelin A, Perez J, Ardaillou R, Baud L: Cytokine formation within rat glomeruli during experimental endotoxemia. J Am Soc Nephrol 1993;3:1783-1791.
9. Cunningham P, Dyanov H, Park P, Wang J, Newell K, Quigg R: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002;168:5817-5823
10. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, Sellevold OF, Espevik T, Sundan A: Inflammatory response after open heart surgery: Release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 2002;105:685-690.
11. Bonventre J, Weinberg J: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003;14:2199-2210.
12. Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, Te Loo M, Monnens L, Remuzzi G, Morigi M: Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 2002;62: 846-856.
13. Solez K, Morel-Maroger L, Sraer J-D: The morphology of acute tubular necrosis in man: Analysis of 57 renal biopsis and a comparison with glycerol model. Medicine 1979;58:362-376.
14. Burne M, Daniels F, El Ghandour A, Mauiyyedi S, Colvin R, O'Donnell M, Rabb H: Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001;108:1283-1290.
15. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, Star RA: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001;60:2118-2128.
16. Ramesh G, Reeves W: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002;110:835-842.
17. Burne-Taney M, Kofler J, Yokota N, Weisfeldt M, Traystman R, Rabb H: Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol 2003;285:F87-F94.
18. Kelly KJ, Williams WWJ, Colvin RB, Bonventre JV: Antibody to inter-cellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994;91:812-816.
19. Gormley SM, McBride WT, Armstrong MA, Young IS, McClean E, MacGowan SW, Campalani G, McMurray TJ: Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology 2000;93:1210-1216;discussion 1215A.
20. Himmelfarb J, Sezer M, Shyr Y, Freedman S, Ikizler T, Becker K, Spratt D, Group PS: A prospective analysis of pro-inflammatory and anti-inflammatory cytokines in patients with acute renal failure (abstract). J Am Soc Nephrol 2002;13:5A.
21. Iglesias J, Marik PE, Levine JS, Investigators NIS: Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis 2003;41:62-75.
22. Venter J, Adams M, Myers E: The sequence of the human genome. Science 2001;291:1304-1351.
23. Guttmacher A, Collins F: Genomic medicine: Genomic medicine - A primer. N Engl J Med 2002;347:1512-1520.
24. Haukim N, Bidwell J, Smith A, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott M, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: On-line databases, supplement 2. Genes Immun 2002;3:313-330.
25. Nussbaum R, McInnes R, Willard H (eds): Genetic variation in individuals: Mutation and polymorphism; in Thompson & Thompson Genetics in Medicine, ed 6. Philadelphia, Saunders, 2001, pp 79-94.
26. Abraham LJ, Kroeger KM: Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease. J Leukoc Biol 1999;66:562-566.
27. Morse H, Olomolaiye O, Wood N, Keen L, Bidwell J: Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine 1999;11:789-795.
28. Wilson AG, Symons JA, McDowell TL, McDewitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor- promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
29. Abraham L, Du D, Zahedi K, Dawkins R, Whitehead A: Haplotypic polymorphisms of the TNFB gene. Immunogenetics 1991;33:50-53.
30. Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Baek L, Nerup J: A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991;33:37-49
31. Messer G, Spengler U, Jung M, Honold G, Blomer K, Pape G, Riethmuller G, Weiss E: Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991;173:209-219.
32. Heesen M, Kunz D, Bachmann-Mennenga B, Merk H, Bloemeke B: Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 2003;31:211-214.
33. Mira J-P, Cariou A, Grall F, Delclaux C, Losser M-R, Heshmati F, Cheval C, Monchi M, Teboul J-L, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut J-F: Association of TNF2, a TNF- [alpha] promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. JAMA 1999;282:561-568.
34. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000;28: 2733-2736.
35. Wunderink RG, Waterer GW, Cantor RM, Quasney MW: Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. Chest 2002;121:87S.
36. Majetschak M, Flohe S, Obertacke U, Schroder J, Staubach K, Nast-Kolb D, Schade FU, Stuber F: Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999;230: 207-214.
37. Waterer G, ElBahlawan L, Quasney M, Zhang Q, Kessler L, Wunderink R: Heat shock protein 70-2 + 1267 AA homozygotes have an increased risk of septic shock in adults with communityacquired pneumonia. Crit Care Med 2003;31:1367-1372.
38. Yende S, Quasney MW, Tolley E, Zhang Q, Wunderink RG: Association of tumor necrosis factor gene polymorphisms and prolonged mechanical ventilation after coronary artery bypass surgery. Crit Care Med 2003;31:133-140.
39. Treszl A, Toth-Heyn P, Kocsis I, Nobilis A, Schuler A, Tulassay T, Vasarhelyi B: Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 2002;17: 713-717.
40. Jaber B, Rao M, Guo D, Balakrishnan V, Perianayagam M, Freeman R, Pereira B: Cytokine promoter gene polymorphisms and mortality in acute renal failure. Cytokine 2004;25:212-219.
41. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P: Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-1108.
42. van der Pol WL HT, Vidarsson G, van der Linden MW, Jansen MD, Keijsers V, de Straat FG, Westerdaal NA, de Winkel JG, Westendorp RG: Relevance of Fc-gamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis 2001;184:1548-1555.
43. Gallagher P, Lowe G, Fitzgerald T, Bella A, Greene C, McElvaney N, O'Neill S: Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003;58: 154-156.
44. Lowe PR, Galley HF, Abdel-Fattah A, Webster NR: Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003;31:34-38.
45. Ridker P, Stampfer M: Assessment of genetic markers for coronary thrombosis: Promise and precaution. Lancet 1999;353:687-688.
46. Newman TB, Browner WS, Hulley SB: Enhancing causal inference in observational studies; in Hulley SB, Cummings SR (eds): Designing Clinical Research. Baltimore, Williams & Wilkins, 1988, pp 98-109.
47. Jo S, Hu X, Kobayashi H, Lizak M, Miyaji T, Koretsky A, Star R: Detection of inflammation following renal ischemia by magnetic resonance imaging. Kidney Int 2003;64:43-51.
48. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NF-kB activity through induction of IkB synthesis. Science 1995;270:286-290.
49. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-394
50. Doherty GM, Jensen JC, Alexander H, Buresh CM, Norton JA: Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991;110:192-198.
51. Parry G, Mackman N: Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol 1997;159:5450-5456.
52. Semmler J, Wachtel H, Endres S: The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-production by human mono-nuclear cells. Int J Immunopharmacol 1993;15:409-413.
53. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G: Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993;177:1675-1680.
54. Moore K, de Waal M, Coffman R, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;765:683-765.
55. Pajkrt D, Camoglio L, Tiel-van Buul M, de Bruin K, Cutler D, Affrime M, Rikken G, van der Poll T, ten Cate J, van Deventer S: Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration. J Immunol 1997;158:3971-3977.
56. Bermudez LE, Wu M, Young LS: Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor. Lymphokine Res 1990;9:137-145.
57. Brenner S, Prosch S, Schenke-Layland K, Riese U, Gausmann U, Platzer C: cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J Biol Chem 2003;278:5597-5604.
58. Mascali J, Cvietusa P, Negri J, Borish L: Anti-inflammatory effects of theophylline: Modulation of cytokine production. Ann Allergy Asthma Immunol 1996;77:34-38.
59. Escofier N, Boichot E, Germain N, Silva P, Martins M, Lagente V: Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung. Fundam Clin Pharmacol 1999;13:96-101.
60. van Furth A, Seijmonsbergen E, Langermans J, van der Meide P, van Furth R: Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes. Clin Diagn Lab Immunol 1995;2:689-692.
61. Cho M, Kim W, Min S, Min D, Min J, Lee S, Park S, Cho C, Kim H: Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. Arthritis Rheum 2002;46:42-51.
62. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, Leclerc JL, Vincent JL: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996;119:76-80.
63. Jaber BL, Liangos O, Pereira BJ, Balakrishnan VS: Polymorphism of immunomodulatory cytokine genes: Implications in acute renal failure. Blood Purif 2004;22:101-111.
64. Nadel S, Newport MJ, Booy R, Levin M: Variation in the tumor necrosis factor-6 promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174:878-880.
65. Zhang D, Li J, Jiang Z, Yu B, Tang X: Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. J Surg Res 2003;112:138-143.
66. Stuber F, Petersen M, Bokelmann F, Schade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-384.
67. Keijsers V, Verweij C, Westendorp R, et al: IL-10 promotor haplotypes: Discrepancy between lack of functionality in transfection assays and skewed distribution in meningococcal disease. Genes Immun 1999;1:78-79.